Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 1 of 32 for:    odyssey outcomes
Previous Study | Return to List | Next Study

ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2016 by Sanofi
Regeneron Pharmaceuticals
Information provided by (Responsible Party):
Sanofi Identifier:
First received: August 8, 2012
Last updated: October 12, 2016
Last verified: October 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2018
  Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):